#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2525	1028.7	0	.	n	.	0	C451T	SNP	451	451	C	842	842	T	1334	T,C,G,A	943,302,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2525	1028.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1575	1575	C	1369	C,T,G,A	1230,2,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2525	1028.7	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1841	1841	C	1425	C,T,A	999,288,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2525	1028.7	0	HET	.	.	.	C207T,G	.	207	207	C	598	598	C	1056	C,T,G	702,240,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19372	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4008	1146.5	0	.	n	.	0	T695C	SNP	695	695	T	1357	1357	C	1403	C,A,G	1271,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19372	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4008	1146.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2633	2633	C	1293	C,G,A	1188,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19372	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4008	1146.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2707	2707	A	1227	A	1132	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19372	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4008	1146.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3259	3259	C	1267	C,A,T	1172,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1122	folP	855	855	100.0	folP.l6.c30.ctg.1	2296	116.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1551	1553	AGC	167;166;166	A,G;G;C,A	154,1;156;154,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3969	155.3	1	SNP	p	S91F	1	.	.	271	273	TTC	921	923	TTC	165;165;166	T;T;C	144;141;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3969	155.3	1	SNP	p	G95N	0	.	.	283	285	GGC	933	935	GGC	172;172;172	G;G;C	158;158;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2546	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3969	155.3	1	SNP	p	D95G	1	.	.	283	285	GGC	933	935	GGC	172;172;172	G;G;C	158;158;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	854	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1547	132.8	1	SNP	p	G45D	0	.	.	133	135	GGC	705	707	GGC	205;207;207	G,C;G;C	190,1;190;193	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	588	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1555	91.5	0	.	n	.	0	A197.	DEL	197	197	A	854	854	A	205	A	191	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	181.2	1	SNP	p	D86N	0	.	.	256	258	GAC	757	759	GAC	165;165;171	G;A,C;C,T	125;105,1;130,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	181.2	1	SNP	p	R87I	0	.	.	259	261	CGT	760	762	CGT	170;170;170	C;G;T,G	140;116;129,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	181.2	1	SNP	p	R87W	0	.	.	259	261	CGT	760	762	CGT	170;170;170	C;G;T,G	140;116;129,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	181.2	1	SNP	p	S87R	1	.	.	259	261	CGT	760	762	CGT	170;170;170	C;G;T,G	140;116;129,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3391	181.2	1	SNP	p	S88P	0	.	.	262	264	TCC	763	765	TCC	171;173;172	T;C,T,G;C	142;143,1,1;144	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2426	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3334	175.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1879	1881	GGC	170;173;174	G;G;C	150;155;145	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1542	1544	GCC	311;311;311	G,T,A;C;C,A	285,1,1;288;287,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1545	1547	ATG	312;312;313	A;T,G;G	288;288,1;290	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1557	1559	ACC	314;316;312	A,C,G;C;C,A	284,2,1;291;287,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1557	1559	ACC	314;316;312	A,C,G;C;C,A	284,2,1;291;287,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2058	2060	ACC	298;298;296	A,C;C,A;C,T,A	268,2;259,7;273,1,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2112	2114	GCG	276;273;274	G;C,G;G,C,T	250;217,1;236,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2112	2114	GCG	276;273;274	G;C,G;G,C,T	250;217,1;236,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2235	2237	GGT	212;212;209	G,C;G,T;T,G	202,1;199,5;199,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2244	2246	AGC	185;184;183	A,G,C;G;C,G,T	135,1,1;155;135,4,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2300	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2682	204.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2262	2264	CCG	161;155;155	C,G,A;C;G,C	145,2,1;138;143,3	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2950	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3486	197.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1697	1699	CCG	279;278;281	C,G,T;C,A,T;G,C,A	209,9,2;233,2,1;182,16,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1108	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2280	116.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	798	798	C	83	C	63	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	445	447	GTT	197;194;194	G;T,G,C;T,G	188;182,1,1;183,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	G48E	NONSYN	142	144	GGA	454	456	GAA	190;189;190	G,A;A;A	176,1;178;179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	I75V	NONSYN	223	225	ATT	535	537	GTT	204;204;204	G;T;T	190;178;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	S89T	NONSYN	265	267	AGC	577	579	ACC	219;220;218	A,C,T,G;C;C,G	181,2,1,1;202;202,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	I98V	NONSYN	292	294	ATC	604	606	GTC	217;218;217	G;T,G;C	195;186,1;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	A109V	NONSYN	325	327	GCC	637	639	GTC	172;173;173	G,C;T,G;C	143,3;137,1;156	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	703	705	TAT	213;230;231	T,G,A;A;T,A	199,3,1;219;183,5	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	712	714	GAG	229;232;230	G,A,C,T;A;G	214,1,1,1;215;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	715	717	CTT	232;232;233	C;T,G;T,G,C	213;219,1;222,2,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	730	732	AAA	231;231;231	A;A;A	222;222;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	739	741	GGA	229;234;235	G,C;G;A,G	220,1;221;221,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1422	porB1b	1038	1038	97.5	porB1b.l15.c4.ctg.1	1979	170.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	763	765	GCA	227;225;225	G,C;C;A	214,1;209;203	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6266	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5187	289.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	786	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1534	124.7	1	SNP	p	V57M	1	.	.	169	171	ATG	806	808	ATG	252;251;252	A;T;G	236;238;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
